BRIEF-Bausch + Lomb confirms submission of Vesneo(TM) NDA to US FDA
July 24 (Reuters) - Nicox Sa :
* Noted the confirmation by Valeant Pharmaceuticals International Inc's., wholly owned subsidiary, Bausch + Lomb, that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for Vesneo(TM)
* Nicox's advanced pipeline, partnered with Bausch + Lomb / Valeant, features Vesneo(TM), a pre-NDA candidate for glaucoma
Source text for Eikon:
Further company coverage: (Gdynia Newsroom)
© Thomson Reuters 2017 All rights reserved.